BackgroundCheck.run
Search For

Donald I Foster DeceasedRancho Mirage, CA

Known as:
Donald Isle Foster Donald Isle Rev Foster Donald Tr Foster Donald Te Te Foster Donald Isle Foster Revocable Donald Im Kleven Donald F Oster David Foster Don Foster
Related to:
Suriya Macdonald Sheldon R Rnett Barbara J Arnett 76 Suzanne Macdonald Cox 84 Evie Arnett 93 Paul J Arnett Terry P Arnett 72 Allison M Cox Tracey S Brown 70 Greg Macdonald Irene Ga Cox

Donald Foster Phones & Addresses

Rancho Mirage, CA   

1221 Minor Ave, Seattle, WA 98101    206-4475665   

1915 10Th St, Seattle, WA 98102    206-3256161   

123 Jackson St, Seattle, WA 98104    360-5982356   

Palm Springs, CA   

Poulsbo, WA   

Concord, NC   

Get Report
Control this profile

Mentions for Donald I Foster

Career records & work history

Medicine Doctors

Donald Foster Photo 1

Donald W Foster, Tacoma WA - LMFT

Specialties:
Marriage & Family Therapy
Address:
Ave Suite 2006-A, Tacoma, WA 98431
253-9673456 (Phone)
Languages:
English

Donald B. Foster

Specialties:
Emergency Medicine
Work:
Waynesboro Hospital Emergency Medicine
501 E Main St, Waynesboro, PA 17268
717-7653400 (phone) 717-7653408 (fax)
Education:
Medical School
Philadelphia College of Osteopathic Medicine
Graduated: 1972
Procedures:
Arthrocentesis, Cardioversion, Lumbar Puncture, Vaccine Administration
Conditions:
Acute Pharyngitis, Acute Sinusitis, Acute Upper Respiratory Tract Infections, Fractures, Dislocations, Derangement, and Sprains, Skin and Subcutaneous Infections
Languages:
English
Description:
Dr. Foster graduated from the Philadelphia College of Osteopathic Medicine in 1972. He works in Waynesboro, PA and specializes in Emergency Medicine. Dr. Foster is affiliated with Waynesboro Hospital.

Donald L. Foster

Specialties:
Pediatric Emergency Medicine
Work:
Arkansas Childrens Hospital Emergency
1 Childrens Way, Little Rock, AR 72202
501-3641185 (phone) 501-3646931 (fax)
Education:
Medical School
Louisiana State University School of Medicine at Shreveport
Graduated: 1982
Conditions:
Bronchial Asthma, Constipation, Croup, Pneumonia, Acute Conjunctivitis, Acute Pharyngitis, Acute Upper Respiratory Tract Infections, Anxiety Phobic Disorders, Appendicitis, Bacterial Pneumonia, Dehydration, Epilepsy, Hemolytic Anemia, Infectious Mononucleosis, Otitis Media, Poisoning by Drugs, Meds, or Biological Substances, Sickle-Cell Disease, Skin and Subcutaneous Infections, Tempromandibular Joint Disorders (TMJ), Viral Pneumonia
Languages:
English
Description:
Dr. Foster graduated from the Louisiana State University School of Medicine at Shreveport in 1982. He works in Little Rock, AR and specializes in Pediatric Emergency Medicine. Dr. Foster is affiliated with Arkansas Childrens Hospital and University Arkansas Of Medical Sciences.
Donald Foster Photo 2

Donald William Foster

Specialties:
Anesthesiology
Education:
New York Medical College (1988)

License Records

Donald Foster

Licenses:
License #: 13978 - Expired
Category: Professional
Issued Date: Sep 3, 1981
Expiration Date: Dec 31, 2014

Publications & IP owners

Wikipedia

Donald Foster Photo 41

Dald Foster

From Wikipedia, the free encyclopedia. Jump to: navigation, search. Donald Foster may refer to: Donald Foster (actor) (18891969), American film and television ...
Donald Foster Photo 42

Dald Wayne Foster

Donald Wayne Foster (born 1950) is a professor of English at Vassar College in New York. He is known for his work dealing with various issues of ...

Us Patents

Protease-Activated Receptor Par4 Zchemr2

US Patent:
6436400, Aug 20, 2002
Filed:
Jan 7, 2000
Appl. No.:
09/479130
Inventors:
Wen-feng Xu - Mukilteo WA
Scott R. Presnell - Seattle WA
David P. Yee - Seattle WA
Donald C. Foster - Seattle WA
Assignee:
ZymoGenetics, Inc. - Seattle WA
University of Washington - Seattle WA
International Classification:
C07K 1628
US Classification:
4241431, 53038822
Abstract:
The present invention relates to polynucleotide and polypeptide molecules for PAR4, a novel member of the protease-activated receptor family. The polypeptides, and polynucleotides encoding them, mediate biological responses and/or cellular signaling in response to proteases. Protease cleavage of PAR4 exposes a PAR4 extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. PAR4 may be used as a target in drug screening, and further used to identify proteinaceous or non-proteinaceous PAR4 agonists and antagonists. The present invention also includes antibodies to the PAR4 polypeptides.

Dna Sequence Coding For Protein C

US Patent:
RE37958, Jan 7, 2003
Filed:
Jun 15, 2001
Appl. No.:
09/882150
Inventors:
Donald C. Foster - Seattle WA
Earl W. Davie - Bellevue WA
Assignee:
Board of Regents of the University of Washington - Seattle WA
International Classification:
C12N 1500
US Classification:
4353201, 435226, 435 691, 435440, 43525233, 536 232
Abstract:
Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.

Methods Of Using Zalpha11 Ligand

US Patent:
6605272, Aug 12, 2003
Filed:
Aug 3, 2001
Appl. No.:
09/923246
Inventors:
Julia E. Novak - Bainbridge Island WA
Scott R. Presnell - Tacoma WA
Cindy A. Sprecher - Seattle WA
Donald C. Foster - Lake Forest Park WA
Richard D. Holly - Seattle WA
Jane A. Gross - Seattle WA
Janet V. Johnston - Seattle WA
Andrew J. Nelson - Shoreline WA
Stacey R. Dillon - Seattle WA
Angela K. Hammond - Maple Valley WA
Assignee:
ZymoGenetics, Inc. - Seattle WA
International Classification:
A61K 4500
US Classification:
424 852, 424 851, 4241691, 4241731, 4241741, 514 2, 514 12
Abstract:
The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Method For Treating Inflammation Using Soluble Receptors To Interleukin-20

US Patent:
6610286, Aug 26, 2003
Filed:
Dec 22, 2000
Appl. No.:
09/746359
Inventors:
Penny Thompson - Snohomish WA
Donald C. Foster - Lake Forest Park WA
Wenfeng Xu - Mukilteo WA
James D. Kelly - Mercer Island WA
Hal Blumberg - Seattle WA
Yasmin A. Chandrasekher - Mercer Island WA
Assignee:
ZymoGenetics, Inc. - Seattle WA
International Classification:
A61K 4500
US Classification:
424 852, 424 851, 4241451, 514 12, 514886, 530350
Abstract:
A method for treating IL-20 induced inflammation. An antagonist to IL-20 is administered to treat inflammation and associated diseases. The antagonist can be an antibody that binds to IL-20 or its receptor or a soluble receptor that binds to IL-20. Examples of such diseases are adult respiratory disease, psoriasis, eczema, contact dermatitis, atopic dermatitis, septic shock, multiple organ failure, inflammatory lung injury, bacterial pneumonia, inflammatory bowel disease, rheumatoid arthritis, asthma, ulcerative colitis and Crohns disease.

Antibodies To Human Kunitz-Type Inhibitor

US Patent:
6656746, Dec 2, 2003
Filed:
Jul 13, 2001
Appl. No.:
09/904621
Inventors:
Cindy A. Sprecher - Seattle WA
Walt Kisiel - Albuquerque NM
Donald C. Foster - Seattle WA
Assignee:
ZymoGenetics, Inc. - Seattle WA
University of New Mexico - Albuquerque NM
International Classification:
C07K 1638
US Classification:
436547, 5303879, 5303881, 53038825, 5303893, 435325, 435326
Abstract:
The present invention provides isolated DNA molecules comprising a DNA segment encoding novel human Kunitz-type inhibitors. Also provided are DNA constructs comprising a first DNA segment encoding a novel human Kunitz-type inhibitor wherein said first DNA segment is operably linked to additional DNA segments required for the expression for the first DNA segment, host cells containing such DNA constructs, methods for producing proteins from the host cells, as well as antibodies directed towards same.

Cytokine Zalpha11 Ligand Polynucleotides

US Patent:
6686178, Feb 3, 2004
Filed:
Nov 15, 2002
Appl. No.:
10/295723
Inventors:
Julia E. Novak - Bainbridge Island WA
Scott R. Presnell - Tacoma WA
Cindy A. Sprecher - Seattle WA
Donald C. Foster - Lake Forest Park WA
Richard D. Holly - Seattle WA
Jane A. Gross - Seattle WA
Janet V. Johnston - Seattle WA
Andrew J. Nelson - Shoreline WA
Stacey R. Dillon - Seattle WA
Angela K. Hammond - Maple Valley WA
Assignee:
ZymoGenetics, Inc. - Seattle WA
International Classification:
C12N 1524
US Classification:
435 6952, 435 691, 435 701, 4353201, 435325, 4241301, 4241431, 536 231, 536 241
Abstract:
The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

Dna Sequence Coding For Protein C

US Patent:
RE38981, Feb 14, 2006
Filed:
Aug 13, 2002
Appl. No.:
10/217105
Inventors:
Donald C. Foster - Seattle WA, US
Earl W. Davie - Bellevue WA, US
Assignee:
Board of Regents of the University of Washington - Seattle WA
International Classification:
C12N 15/00
C12N 9/64
C07H 15/12
US Classification:
4353201, 435226, 435 691, 435440, 43525233, 536 232
Abstract:
Genomic and cDNA sequences coding for a protein having substantially the same biological activity as human protein C are disclosed. Recombinant plasmids and bacteriophage transfer vectors incorporating these sequences are also disclosed.

Protease-Activated Receptor Par4 (Zchemr2)

US Patent:
7084253, Aug 1, 2006
Filed:
Jun 28, 2002
Appl. No.:
10/187049
Inventors:
Wenfeng Xu - Mukilteo WA, US
Scott R. Presnell - Tacoma WA, US
David P. Yee - Cambridge MA, US
Donald C. Foster - Lake Forest Park WA, US
Assignee:
ZymoGenetics, Inc. - Seattle WA
International Classification:
C07K 14/705
US Classification:
530350
Abstract:
The present invention relates to polynucleotide and polypeptide molecules for PAR4, a novel member of the protease-activated receptor family. The polypeptides, and polynucleotides encoding them, mediate biological responses and/or cellular signaling in response to proteases. Protease cleavage of PAR4 exposes a PAR4 extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. PAR4 may be used as a target in drug screening, and further used to identify proteinaceous or non-proteinaceous PAR4 agonists and antagonists. The present invention also includes antibodies to the PAR4 polypeptides.

Isbn (Books And Publications)

Sourcebook For Research In Music

Author:
Donald H. Foster
ISBN #:
0253213231

Sourcebook For Research In Music

Author:
Donald H. Foster
ISBN #:
0253217806

Sourcebook For Research In Music

Author:
Donald H. Foster
ISBN #:
0253314763

Sourcebook For Research In Music

Author:
Donald H. Foster
ISBN #:
0253346118

Jean Philippe Rameau: A Guide To Research

Author:
Donald H. Foster
ISBN #:
0824056450

Tapas, Wines &Amp; Good Times

Author:
Donald Leroy Foster
ISBN #:
0809248778

Prints In The Public Library

Author:
Donald Leroy Foster
ISBN #:
0810805790

Managing The Catalog Department

Author:
Donald Leroy Foster
ISBN #:
0810808366

Possible Relatives

Cynthia D Foster  David S Foster  Davie A Foster  Davonne Foster  Dawn M Foster  Dax C Foster  Dayna Foster  Donald R Johnson  Donald Stamps  Donald L Stanchfield 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.